AngioDynamics announced the launch of the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV), a new clinical study aimed at evaluating the efficacy and safety of their AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System in the treatment of acute intermediate-risk pulmonary embolism (PE).
Learn More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
It is with great excitement that we announce that @NorthwellHealth, led by @DrRastinehad, is active and enrolling patients for the PRESERVE Study.
Congratulations Dr. Jeffrey Nix of UAB Urologic Oncology for becoming the first Urologist in the state of Alabama to perform a NanoKnife System ablation procedure! We look forward to our continued partnership and advancing treatment options for patients in Alabama! @UABUroOnc
TODAY: Join AngioDynamics' Sr. Vice President of IT, Kim Seabury, as a featured panelist for the @CEG_NY/@MedTechAssoc's EmpireStateFocus’22 event! Learn more & register free: https://registration.socio.events/e/albanycapitalreg
AngioDynamics thanks @SIRspecialists and the SIR Foundation for presenting us with a CAPstone Award in recognition of our philanthropic support. We are proud to support the work of SIR & help drive the development and use of minimally invasive treatment solutions. #SIR22BOS
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
